Literature DB >> 14697664

Targeting the EphA4 receptor in the nervous system with biologically active peptides.

Keith K Murai1, Louis N Nguyen, Mitchell Koolpe, Rebecca McLennan, Catherine E Krull, Elena B Pasquale.   

Abstract

EphA4 is a member of the Eph family of receptor tyrosine kinases and has important functions in the developing and adult nervous system. In the adult, EphA4 is enriched in the hippocampus and cortex, two brain structures critical for learning and memory. To identify reagents that can discriminate between the many Eph receptors and selectively target EphA4, we used a phage display approach. We identified three 12-amino acid peptides that preferentially bind to EphA4. Despite lack of a common sequence motif, these peptides compete with each other for binding to EphA4 and antagonize ephrin binding and EphA4 activation at micromolar concentrations, indicating that they bind with high affinity to the ephrin-binding site. Furthermore, one of the peptides perturbs the segmental migration of EphA4-positive neural crest cells in chick trunk organotypic explants. Hence, this peptide can disrupt the physiological function of endogenous EphA4 in situ. We also identified additional peptides that bind to EphA5 and EphA7, two other receptors expressed in the nervous system. This panel of peptides may lead to the development of pharmaceuticals that differentially target Eph receptors to modulate neuronal function in specific regions of the nervous system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14697664     DOI: 10.1016/j.mcn.2003.08.006

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  45 in total

Review 1.  Targeting Eph receptors with peptides and small molecules: progress and challenges.

Authors:  Roberta Noberini; Ilaria Lamberto; Elena B Pasquale
Journal:  Semin Cell Dev Biol       Date:  2011-10-25       Impact factor: 7.727

Review 2.  Eph receptors and ephrins in cancer: bidirectional signalling and beyond.

Authors:  Elena B Pasquale
Journal:  Nat Rev Cancer       Date:  2010-03       Impact factor: 60.716

3.  Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets.

Authors:  Nicolas Prévost; Donna S Woulfe; Hong Jiang; Timothy J Stalker; Patrizia Marchese; Zaverio M Ruggeri; Lawrence F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-01       Impact factor: 11.205

4.  Structure of the ligand-binding domain of the EphB2 receptor at 2 A resolution.

Authors:  Yehuda Goldgur; Sari Paavilainen; Dimitar Nikolov; J P Himanen
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-01-31

5.  Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.

Authors:  Roberta Noberini; Mitchell Koolpe; Satyamaheshwar Peddibhotla; Russell Dahl; Ying Su; Nicholas D P Cosford; Gregory P Roth; Elena B Pasquale
Journal:  J Biol Chem       Date:  2008-08-26       Impact factor: 5.157

Review 6.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

Review 7.  Cell-cell signaling via Eph receptors and ephrins.

Authors:  Juha-Pekka Himanen; Nayanendu Saha; Dimitar B Nikolov
Journal:  Curr Opin Cell Biol       Date:  2007-10-24       Impact factor: 8.382

8.  Structure-activity relationship analysis of peptides targeting the EphA2 receptor.

Authors:  Sayantan Mitra; Srinivas Duggineni; Mitchell Koolpe; Xuejun Zhu; Ziwei Huang; Elena B Pasquale
Journal:  Biochemistry       Date:  2010-08-10       Impact factor: 3.162

Review 9.  Targeting kinase signaling pathways with constrained peptide scaffolds.

Authors:  Laura E Hanold; Melody D Fulton; Eileen J Kennedy
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

10.  Modifications of a Nanomolar Cyclic Peptide Antagonist for the EphA4 Receptor To Achieve High Plasma Stability.

Authors:  Erika J Olson; Bernhard C Lechtenberg; Chunxia Zhao; Elena Rubio de la Torre; Ilaria Lamberto; Stefan J Riedl; Philip E Dawson; Elena B Pasquale
Journal:  ACS Med Chem Lett       Date:  2016-06-25       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.